| The Card1 nuclease provides defence during type III CRISPR immunity JT Rostøl, W Xie, V Kuryavyi, P Maguin, K Kao, R Froom, DJ Patel, ... Nature 590 (7847), 624-629, 2021 | 86 | 2021 |
| Cleavage of viral DNA by restriction endonucleases stimulates the type II CRISPR-Cas immune response P Maguin, A Varble, JW Modell, LA Marraffini Molecular cell 82 (5), 907-919. e7, 2022 | 34 | 2022 |
| Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes A Varble, E Campisi, CW Euler, P Maguin, A Kozlova, J Fyodorova, ... Nature microbiology 6 (12), 1516-1525, 2021 | 34 | 2021 |
| A CRISPR-Cas9–integrase complex generates precise DNA fragments for genome integration S Jakhanwal, BF Cress, P Maguin, MJ Lobba, LA Marraffini, JA Doudna Nucleic acids research 49 (6), 3546-3556, 2021 | 18 | 2021 |
| RecT Recombinase Expression Enables Efficient Gene Editing in Enterococcus spp. V Chen, ME Griffin, P Maguin, A Varble, HC Hang Applied and environmental microbiology 87 (18), e00844-21, 2021 | 13 | 2021 |
| From the discovery of DNA to current tools for DNA editing P Maguin, LA Marraffini Journal of Experimental Medicine 218 (4), 2021 | 8 | 2021 |
| LIM Protein Ajuba associates with the RPA complex through direct cell cycle-dependent interaction with the RPA70 subunit S Fowler, P Maguin, S Kalan, D Loayza Scientific Reports 8 (1), 9536, 2018 | 6 | 2018 |
| Restriction-Modification and CRISPR-Cas Systems: Cooperation Between Innate and Adaptive Immunity in Prokaryotes P Maguin | | 2022 |
| Abstract B44: Lysyl oxidases suppress pancreatic cancer progression and inhibit FAK and ERK signaling M Shields, P Maguin, C Giuliano, S Dallas, JE Wilkinson, M Egeblad Cancer Research 78 (10_Supplement), B44-B44, 2018 | | 2018 |
| LIM protein Ajuba participates in the ATR response by direct interaction with RPA70 SWS Fowler, D Loayza, P Maguin Cancer Research 77 (13_Supplement), 1408-1408, 2017 | | 2017 |
| Abstract B28: Dynamic interplay between type I collagen signaling and invasion in pancreatic cancer MA Shields, P Maguin, SL Dallas, M Egeblad Cancer Research 76 (24_Supplement), B28-B28, 2016 | | 2016 |
| Abstract A43: Lysyl oxidases are poor therapeutic targets in pancreatic cancer MA Shields, P Maguin, P Kumar, SL Dallas, M Egeblad Cancer Research 75 (13_Supplement), A43-A43, 2015 | | 2015 |
Luciano MarraffiniThe Rockefeller University在 rockefeller.edu 的电子邮件经过验证
